Partnering with TGV-Inhalonix

TGV-Laboratoriesis dedicated to the development of novel drug candidates to treat areas of high unmet medical need. As a research-based and innovation-driven company, we devote our science to deepening the understanding of pathological processes and uncovering new approaches to the development of life-saving drugs.  We believe that we can best achieve these goals together with partners who can supplement and complement our strengths and capabilities.

If you are interested in partnering with us in the development of this promising drug candidate, please contact us at

TGV-Laboratories has successful partnerships involving companies, funds and academic institutions. Here are some examples of our partnerships.